Explore
Trendline
ImmunityBio Faces Securities Class Action Over Misleading Statements
ImmunityBio Faces Securities Class Action Over Misleading Statements
Read More
Trendline
Faruqi Faruqi, LLP Reminds Medpace Investors of Class Action Deadline Amid Allegations of Misleading Statements
Faruqi Faruqi, LLP Reminds Medpace Investors of Class Action Deadline Amid Allegations of Misleading Statements
Read More
Trendline
Faruqi Faruqi, LLP Alerts Medpace Investors of Securities Class Action Deadline
Faruqi Faruqi, LLP Alerts Medpace Investors of Securities Class Action Deadline
Read More
Trendline
ImmunityBio Faces Class Action Lawsuit Over Misleading Statements on Cancer Drug
ImmunityBio Faces Class Action Lawsuit Over Misleading Statements on Cancer Drug
Read More
Trendline
Rosen Law Firm Urges Veritone Investors to Join Securities Class Action Before Deadline
Rosen Law Firm Urges Veritone Investors to Join Securities Class Action Before Deadline
Read More
Trendline
Immutep Faces Securities Class Action as Trial Discontinuation Impacts Investors
Immutep Faces Securities Class Action as Trial Discontinuation Impacts Investors
Read More
Trendline
Veritone Investors Encouraged to Lead Securities Fraud Lawsuit
Veritone Investors Encouraged to Lead Securities Fraud Lawsuit
Read More
Trendline
Vital Farms Faces Securities Fraud Lawsuit as Investors Seek Leadership
Vital Farms Faces Securities Fraud Lawsuit as Investors Seek Leadership
Read More
Trendline
Rosen Law Firm Calls on Globant Investors to Join Class Action Lawsuit
Rosen Law Firm Calls on Globant Investors to Join Class Action Lawsuit
Read More
Trendline
Rosen Law Firm Investigates Zillow Group for Potential Securities Class Action
Rosen Law Firm Investigates Zillow Group for Potential Securities Class Action
Read More
Trendline
Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline
Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline
Read More
Trendline
BioLineRx to Announce First Quarter 2026 Financial Results with Conference Call
BioLineRx to Announce First Quarter 2026 Financial Results with Conference Call
Read More